Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

May 30, 2018

Securities and Exchange Commission v. Curative Biosciences, Inc. et al

Track this case

Case Number:

8:18-cv-00925

Court:

California Central

Nature of Suit:

Securities/Commodities

Judge:

Stephen V. Wilson

Firms

Companies

Government Agencies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 12, 2020

    Jury Finds CBD Co. Liable In SEC's $4M Illicit Stock Sale Suit

    A California federal jury sided with the U.S. Securities and Exchange Commission in its suit accusing a hemp company and its executives of pocketing $4 million in proceeds from the unregistered sale of more than 33 million shares of the company's stock, the SEC announced Thursday.

3 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login